Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

EU must step up response to COVID-19, Commission warns as infections spike

Wed, 28th Oct 2020 11:30

BRUSSELS, Oct 28 (Reuters) - The European Commission
proposed on Wednesday a series of new measures to fight the
COVID-19 pandemic in the European Union, saying the new spike in
infections on the continent was "alarming".

As Europe again becomes the world's epicentre of the
pandemic, the EU executive urged the 27 EU governments to do
more and in a more coordinated fashion against the virus.

"The relaxation of applied measures during the summer months
was not always accompanied by steps to build up sufficient
response capacity," the Commission warned in a statement.

To better trace the spread of infections, Brussels said EU
governments should coordinate their testing strategies and make
a larger use of rapid antigen tests, despite the global supply
for these kits is now tightening.

It warned the "current shortfalls in testing capacity"
required swift action.
(Reporting by Francesco Guarascio @fraguarascio)

Related Shares

More News
26 Jun 2024 08:40

TOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in China

(Alliance News) - AstraZeneca PLC on Wednesday celebrated the approval of Tagrisso plus chemotherapy for a cancer form in China, a day after a similar...

25 Jun 2024 09:05

TOP NEWS: AstraZeneca details mixed findings from cancer drug trials

(Alliance News) - AstraZeneca PLC on Tuesday announced a mixed bag of results for two of its leading cancer drugs Imfinzi and Tagrisso.

25 Jun 2024 07:48

LONDON BRIEFING: Mixed bag for Astra drug; Landsec ups Bluewater stake

(Alliance News) - London's FTSE 100 is set to tread water on Tuesday, with a slump for US tech shares overnight keeping a lid on enthusiasm.

25 Jun 2024 07:17

AstraZeneca posts mixed results from recent Imfinzi trials

(Sharecast News) - AstraZeneca announced contrasting results from two phase three trials involving its immunotherapy drug 'Imfinzi', or durvalumab, on...

24 Jun 2024 15:40

US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit

WASHINGTON, June 24 (Reuters) - The U.S. Supreme Court gave a boost on Monday to a challenge by 21 pharmaceutical and medical equipment companies le...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.